John E. Bailey, Jr
2021
In 2021, John E. Bailey, Jr earned a total compensation of $8.7M as Chief Executive Officer and President at G1 Therapeutics, a 1,048% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,000 |
|---|---|
| Option Awards | $3,830,194 |
| Salary | $735,000 |
| Stock Awards | $3,837,861 |
| Other | $8,700 |
| Total | $8,705,755 |
Bailey received $3.8M in stock awards, accounting for 44% of the total pay in 2021.
Bailey also received $294K in non-equity incentive plan, $3.8M in option awards, $735K in salary and $8.7K in other compensation.
Rankings
In 2021, John E. Bailey, Jr's compensation ranked 1,279th out of 12,415 executives tracked by ExecPay. In other words, Bailey earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,279 out of 12,415 | 90th |
Division Manufacturing | 454 out of 5,508 | 92nd |
Major group Chemicals And Allied Products | 166 out of 2,378 | 93rd |
Industry group Drugs | 138 out of 2,099 | 93rd |
Industry Pharmaceutical Preparations | 91 out of 1,549 | 94th |
Source: SEC filing on April 26, 2023.
Bailey's colleagues
We found two more compensation records of executives who worked with John E. Bailey, Jr at G1 Therapeutics in 2021.